TickerFacts.

TG Therapeutics, Inc. (TGTX): Long-Term Debt

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Long-Term Debt is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$100.40M
As of 2023-12-31
+49.8%
3-year compound annual growth
2019-12-31: $28.97M2020-12-31: $29.89M2021-12-31: $67.76M2022-12-31: $71.14M2023-12-31: $100.40M$100.40M
2019-12-31 Long-Term Debt (USD) 2023-12-31
Period endedLong-Term DebtChange YoYSource filing
2023-12-31$100.40M+41.1%2024-02-29, Balance as of period end
2022-12-31$71.14M+5.0%2023-03-01, Balance as of period end
2021-12-31$67.76M+126.7%2023-03-01, Balance as of period end
2020-12-31$29.89M+3.2%2022-03-01, Balance as of period end
2019-12-31$28.97Mn/a2021-03-01, Balance as of period end